{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T14:40:21Z","timestamp":1727534421819},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,28]]},"DOI":"10.7759\/cureus.70385","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T14:09:41Z","timestamp":1727532581000},"source":"Crossref","is-referenced-by-count":0,"title":["Overlap of Sj\u00f6gren's Syndrome and Immune-Mediated Necrotizing Myopathy With Interstitial Lung Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Keiko","family":"Tanimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Egami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach Y","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord. 2018, 28:87-99. 10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.04.002","article-title":"Immune-mediated necrotising myopathy: a critical review of current concepts","volume":"49","author":"Day JA","year":"2019","unstructured":"Day JA, Limaye V. Immune-mediated necrotising myopathy: a critical review of current concepts. Semin Arthritis Rheum. 2019, 49:420-9. 10.1016\/j.semarthrit.2019.04.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian CD","year":"2015","unstructured":"Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol. 2015, 72:996-1003. 10.1001\/jamaneurol.2015.1207","journal-title":"JAMA Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-023-06354-5","article-title":"Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features","volume":"24","author":"Xu L","year":"2023","unstructured":"Xu L, Yang MG, Hu L, Gao H, Ji S. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features. BMC Musculoskelet Disord. 2023, 24:219. 10.1186\/s12891-023-06354-5","journal-title":"BMC Musculoskelet Disord"},{"key":"ref5","article-title":"Myositis in primary Sj\u00f6gren\u2019s syndrome: data from a multicentre cohort","volume":"33","author":"Colafrancesco S","year":"2015","unstructured":"Colafrancesco S, Priori R, Gattamelata A, et al.. Myositis in primary Sj\u00f6gren\u2019s syndrome: data from a multicentre cohort. Clin Exp Rheumatol. 2015, 33:457-64.","journal-title":"Clin Exp Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/s101650300008","article-title":"Myositis in primary Sj\u00f6gren's syndrome: clinical and pathological report","volume":"13","author":"Aoki A","year":"2003","unstructured":"Aoki A, Ono S, Ueda A, et al.. Myositis in primary Sj\u00f6gren's syndrome: clinical and pathological report. Mod Rheumatol. 2003, 13:57-61. 10.3109\/s101650300008","journal-title":"Mod Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche L","year":"2017","unstructured":"Arouche-Delaperche L, Allenbach Y, Amelin D, et al.. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol. 2017, 81:538-48. 10.1002\/ana.24902","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020, 16:689-701. 10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01802-1","article-title":"Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies","volume":"22","author":"Ge Y","year":"2022","unstructured":"Ge Y, Yang H, Xiao X, Liang L, Lu X, Wang G. Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies. BMC Pulm Med. 2022, 22:14. 10.1186\/s12890-021-01802-1","journal-title":"BMC Pulm Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez I","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018, 20:21. 10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki S","year":"2015","unstructured":"Suzuki S, Nishikawa A, Kuwana M, et al.. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis. 2015, 10:61. 10.1186\/s13023-015-0277-y","journal-title":"Orphanet J Rare Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0303-17","article-title":"Development of necrotizing myopathy following interstitial lung disease with anti-signal recognition particle antibody","volume":"57","author":"Kusumoto T","year":"2018","unstructured":"Kusumoto T, Okamori S, Masuzawa K, et al.. Development of necrotizing myopathy following interstitial lung disease with anti-signal recognition particle antibody. Intern Med. 2018, 57:2045-9. 10.2169\/internalmedicine.0303-17","journal-title":"Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals M","year":"2015","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Seror R, et al.. Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford). 2015, 54:2230-8. 10.1093\/rheumatology\/kev200","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13881","article-title":"Prevalence and risk factors of interstitial lung disease in patients with primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"23","author":"He C","year":"2020","unstructured":"He C, Chen Z, Liu S, Chen H, Zhang F. Prevalence and risk factors of interstitial lung disease in patients with primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis. Int J Rheum Dis. 2020, 23:1009-18. 10.1111\/1756-185X.13881","journal-title":"Int J Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200403-417OC","article-title":"Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study","volume":"171","author":"Ito I","year":"2005","unstructured":"Ito I, Nagai S, Kitaichi M, et al.. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005, 171:632-8. 10.1164\/rccm.200403-417OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1338947","article-title":"Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease","volume":"11","author":"Zhang L","year":"2024","unstructured":"Zhang L, Liu X, Fan B, Chen J, Chen J, Li Q, Wu X. Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease. Front Med (Lausanne). 2024, 11:1338947. 10.3389\/fmed.2024.1338947","journal-title":"Front Med (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/301182-overlap-of-sjgrens-syndrome-and-immune-mediated-necrotizing-myopathy-with-interstitial-lung-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T14:09:42Z","timestamp":1727532582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/301182-overlap-of-sjgrens-syndrome-and-immune-mediated-necrotizing-myopathy-with-interstitial-lung-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.70385","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,28]]}}}